CareDx director awarded 9,795 RSUs

Gunasekaran Suresh reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Gunasekaran Suresh reported acquisition or exercise transactions in this Form 4 filing.

CareDx, Inc. director Suresh Gunasekaran reported receiving an equity award of 9,795 shares of Common Stock, represented by restricted stock units (RSUs). These RSUs vest 100% on the earlier of one year after the grant or the day immediately before the first Annual Meeting after the grant, subject to his continuous service. Following this award, he holds 37,248 shares directly.

Insights

Equity compensation analyst

Routine RSU grant increases director’s equity stake at CareDx.

The filing shows director Suresh Gunasekaran receiving 9,795 restricted stock units, a common form of equity compensation for board members. The grant carries no cash cost to him, with a zero transaction price per share.

The RSUs vest in full on the earlier of one year from grant or the day before the first Annual Meeting after grant, conditioned on continuous service. This structure is typical, aligning director incentives with shareholder outcomes over the service period.

After the grant, Gunasekaran directly holds 37,248 shares of Common Stock, indicating a meaningful but routine alignment with the company’s equity. The filing does not show any sales or option exercises, only this compensation-related acquisition.

Insider Trade Summary 10b5-1

Grant/Award: 9,795 shares

Grant/Award 1 txn

Insider Gunasekaran Suresh

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	9,795	$0.00	$0.00

Holdings After Transaction: Common Stock — 37,248 shares (Direct)

Footnotes (1)

1. F1. The reported securities are represented by restricted stock units ("RSUs"), of which the RSUs vests 100% on the earlier of the one year anniversary of grant or the day immediately before the first Annual Meeting that occurs after the grant date., subject to the Reporting Person's continuous service on each applicable vesting date.

Key Figures

RSU grant size: 9,795 shares Transaction price per share: $0.00 per share Shares held after grant: 37,248 shares

3 metrics

RSU grant size 9,795 shares Restricted stock units awarded to director on grant date

Transaction price per share $0.00 per share Stated price for the RSU grant

Shares held after grant 37,248 shares Director’s direct holdings following the RSU award

Key Terms

restricted stock units ("RSUs"), Annual Meeting, continuous service, Form 4

4 terms

restricted stock units ("RSUs") financial

"The reported securities are represented by restricted stock units ("RSUs"), of which the RSUs vests 100%..."

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

Annual Meeting financial

"...on the earlier of the one year anniversary of grant or the day immediately before the first Annual Meeting that occurs..."

A company's annual meeting is a yearly gathering where owners (shareholders) and the board review performance, ask questions, and vote on key matters like electing directors, approving auditor choices, and sometimes setting pay or dividend policies. For investors it matters because decisions made and votes cast can change who runs the company, influence strategy and payouts, and affect the value or direction of their investment—similar to a homeowners’ meeting where rules and leaders that shape your property’s value are decided.

continuous service financial

"..., subject to the Reporting Person's continuous service on each applicable vesting date."

Form 4 regulatory

"INSIDER FILING DATA (Form 4): {"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did CareDx (CDNA) report for Suresh Gunasekaran?

CareDx reported that director Suresh Gunasekaran received 9,795 shares of Common Stock via a grant of restricted stock units. The award is compensation-related, carries a zero purchase price, and increases his directly held position at the company.

How many CareDx shares does Suresh Gunasekaran hold after this Form 4 filing?

After the reported RSU grant, Suresh Gunasekaran directly holds 37,248 shares of CareDx Common Stock. This total reflects his position following the 9,795-share award disclosed in the Form 4 insider transaction filing.

How do the CareDx RSUs granted to Suresh Gunasekaran vest?

The 9,795 RSUs granted to Suresh Gunasekaran vest 100% on the earlier of the one-year anniversary of the grant date or the day immediately before the first Annual Meeting after the grant, provided he remains in continuous service through that vesting date.

Was there any open-market buying or selling in this CareDx (CDNA) insider trade?

No open-market buying or selling occurred. The Form 4 shows a Code A transaction, meaning a grant or award acquisition of 9,795 RSUs at a stated price of $0.00 per share, a standard non-cash equity compensation event for a director.

What does transaction code A mean in this CareDx Form 4 filing?

Transaction code A indicates a grant, award, or other acquisition, rather than an open-market trade. In this case, CareDx granted 9,795 restricted stock units to director Suresh Gunasekaran as equity compensation, increasing his ownership without a purchase transaction.

Are the CareDx RSUs for Suresh Gunasekaran subject to any conditions?

Yes. The RSUs vest only if Suresh Gunasekaran maintains continuous service through the applicable vesting date. Vesting occurs on the earlier of one year from grant or the day immediately before the first Annual Meeting following the grant date, creating a clear service-based condition.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/16/2026 - 05:49 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gunasekaran Suresh

(Last) (First) (Middle)

C/O CAREDX, INC.

8000 MARINA BLVD., 4TH FLOOR

(Street)

BRISBANE CALIFORNIA 94005

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CareDx, Inc. [ CDNA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/12/2026		A		9,795(1)	A	$0	37,248	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported securities are represented by restricted stock units ("RSUs"), of which the RSUs vests 100% on the earlier of the one year anniversary of grant or the day immediately before the first Annual Meeting that occurs after the grant date., subject to the Reporting Person's continuous service on each applicable vesting date.

	/s/ Jeffrey Adam Novack, Attorney-in-Fact	06/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)